December 8, 2020

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention: Ada D. Sarmento
Mary Beth Breslin
Tara Harkins
Lynn Dicker

Re: AbCellera Biologics Inc.

Registration Statement on Form S-1 (File No. 333-250838)

Ladies and Gentlemen:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between December 7, 2020 and the date hereof, approximately 3,750 copies of the Preliminary Prospectus dated December 7, 2020 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.

We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Thursday, December 10, 2020 or as soon thereafter as practicable.

[Signature page follows]

Very truly yours,

CREDIT SUISSE SECURITIES (USA) LLC

STIFEL, NICOLAUS & COMPANY, INCORPORATED

BERENBERG CAPITAL MARKETS LLC

SVB LEERINK LLC

BMO CAPITAL MARKETS CORP.

As representatives of the Underwriters

Credit Suisse Securities (USA) LLC
By:	/s/ John Hoffman
	Name: John Hoffman
	Title:   Managing Director, ECM
Stifel, Nicolaus & Company, Incorporated
By:	/s/ Nathan Thompson
	Name: Nathan Thompson
	Title:   Director
Berenberg Capital Markets LLC
By:	/s/ Zachary Brantly
	Name: Zachary Brantly
	Title:   Head of U.S. ECM
By:	/s/ Matthew Rosenblatt
	Name: Matthew Rosenblatt
	Title:   CCO, Ops. Principal
SVB Leerink LLC
By:	/s/ Ryan Lindquist
	Name: Ryan Lindquist
	Title:   Managing Director
BMO Capital Markets Corp.
By:	/s/ Annette Grimaldi
	Name: Annette Grimaldi
	Title:   Managing Director